<DOC>
	<DOCNO>NCT01795716</DOCNO>
	<brief_summary>1. purpose : To conduct relative bioavailability study single dose multiple dos imatinib mesylate capsule ( Jiangsu Chia-Tai Tianqing Pharmacy Co. Ltd. ) versus Glivec ( Novartis Pharma Stein AG ) . 2 . Experimental Design： Two-period crossover design 3 . Test drug : imatinib mesylate capsule Reference drug : Glivec 4 . Sample size：20</brief_summary>
	<brief_title>Bioequivalence Study Mesylate Imatinib Capsule Chronic Myeloid Leukemia Body</brief_title>
	<detailed_description>To conduct relative bioavailability study single dose multiple dos imatinib mesylate capsule ( Jiangsu Chia-Tai Tianqing Pharmacy Co. Ltd. ) versus Glivec ( Novartis Pharma Stein AG ) compare bioequivalence pharmacokinetics two product 20 patient chronic myeloid leukemia .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Patients chronic myeloid leukemia ; Age : 1865 year , gender : . Weight : standard weight ± 20 % within , avoid weight disparity large ; No previous radiation therapy , chemotherapy , surgery within 1 week treatment imatinib ; Performance status 0 3 ( WHO scale ) ; Life expectancy great 3 month ; No malignancy ; Adequate hepatic , renal , bone marrow function ( WBC≥3.0×109/L，ANC≥1.5×109/L，PLT≥80×109/L . Serum bilirubin≤1.5×the institutional upper limit normal , ALT、ALP≤2.5×the institutional upper limit normal , creatinine≤1.5×the institutional upper limit normal ) ; Ability understand objective study , study procedure , pharmacological property drug possible adverse reaction willingness sign write informed consent . Suffering heart , liver , kidney disease severe acute chronic gastrointestinal disease ; Pregnant lactate woman sensitive drug ; Subjects think unsuitable study investigator ; Inability comply protocol study procedure opinion investigator ; Attending clinical trial attend clinical trial 3 month ago .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>